OBJECTIVE: Earlier diagnosis and treatment of necrotizing enterocolitis (NEC) in preterm infants, before clinical deterioration, might improve outcomes. A monitor that measures abnormal heart rate characteristics (HRC) of decreased variability and transient decelerations was developed as an early warning system for sepsis. As NEC shares pathophysiologic features with sepsis, we tested the hypothesis that abnormal HRC occur before clinical diagnosis of NEC. STUDY DESIGN: Retrospective review of Bells stage II to III NEC cases among infants o34 weeks gestation enrolled in a prospective randomized clinical trial of HRC monitoring at three neonatal intensive care units. RESULT: Of 97 infants with NEC and HRC data, 33 underwent surgical intervention within 1 week of diagnosis. The baseline HRC index from 1 to 3 days before diagnosis was higher in patients who developed surgical vs medical NEC (2.06 ± 1.98 vs 1.22 ± 1.10, P ¼ 0.009). The HRC index increased significantly 16 h before the clinical diagnosis of surgical NEC and 6 h before medical NEC. At the time of clinical diagnosis, the HRC index was higher in patients with surgical vs medical NEC (3.3±2.2 vs 1.9±1.7, Po0.001). CONCLUSION: Abnormal HRC occur before clinical diagnosis of NEC, suggesting that continuous HRC monitoring may facilitate earlier detection and treatment.
INTRODUCTION
Necrotizing enterocolitis (NEC) is the most common acquired intestinal disease of preterm infants, and despite advances in care in the neonatal intensive care unit (NICU), mortality may be as high as 30%. [1] [2] [3] Survivors of NEC have longer hospital stay and are at risk for long-term nutritional and neurologic problems. [4] [5] [6] A major challenge toward improving outcomes is identifying and treating infants in the early stages of NEC, when clinical signs may be subtle and nonspecific. Once more definitive signs appear, adverse outcomes such as extensive bowel necrosis leading to death or short bowel syndrome are more likely. 7 Discovering markers of NEC that appear before overt clinical signs would facilitate earlier goal-directed therapies, which could improve outcomes.
Abnormal heart rate characteristics (HRC) have been established as a biomarker for late-onset neonatal sepsis and mortality in NICU patients. 8 Our group has shown that reduced heart rate variability and transient decelerations often occur in the preclinical phase of sepsis. 9 This finding inspired the development of a monitor that calculates an HRC index, a mathematical representation of decreased beat-to-beat variability and decelerations, which is the fold-increase in probability of sepsis being diagnosed in the next 24 h. 10, 11 In a recent randomized clinical trial (RCT) of 3003 infants, HRC monitoring reduced mortality in very low birth weight (VLBW) infants from 10.2 to 8.1%, a statistically significant and clinically meaningful result. 12 NEC and sepsis share pathophysiologic features, including a systemic inflammatory response, 13 hemodynamic compromise and organ hypoperfusion. 14 We and others have shown that elevated circulating levels of proinflammatory cytokines contribute to decreased heart rate variability. [15] [16] [17] [18] In NEC, serum cytokines are elevated, particularly when there is significant intestinal necrosis or associated bacteremia. 19 Intestinal hypomotility, ileus and bowel distension have also been associated with increased vagal tone and altered HRC in adults. 20, 21 Our studies in preclinical models indicate that peritoneal administration of bacteria or fungi activates vagus nerve pathways leading to transient heart rate decelerations similar to those seen in neonates with sepsis. 22 HRC changes may thus reflect activation of the cholinergic anti-inflammatory pathway, which has a critical role in host defense. 23 Abnormal HRC have not previously been studied in infants with NEC, and we therefore undertook a retrospective review of cases of NEC in VLBW infants during a prospective RCT of HRC monitoring. Our goal was to determine whether the HRC index could identify patients in the early, preclinical phase of disease when aggressive treatment may improve outcomes.
METHODS

Study population
We retrospectively identified all cases of NEC Bell's stage II to III 24 in VLBW (o1500 g) infants admitted from January 2005 to April 2010 to three centers participating in a prospective RCT of HRC monitoring. In the HRC (HeRO) RCT, 3003 VLBW infants in nine NICUs had HRC continuously monitored and were randomized to having their HRC index displayed to 1 clinicians, or not displayed, then followed for 120 days or until death or NICU discharge. Results of this study were published in 2011. 12 Institutional Review Boards of each institution approved the RCT, which required parental consent, and approved retrospective review of deidentified patient data for the current analysis. The three centers participating in the current analysis were the University of Virginia, Wake Forest University (Brenner Children's Hospital and Forsyth Medical Center) and Vanderbilt University. At the University of Virginia, the principle site for the RCT, VLBW infants not enrolled in the HRC trial had HRC monitored but not displayed to clinicians. At the other units, infants not enrolled in the RCT did not have HRC monitored.
NEC diagnosis and clinical features
Through database review, we identified all cases of NEC in the three centers in the date range indicated above, and then identified cases meeting the following criteria: o34 weeks gestational age, clinical and radiographic evidence of Bell's stage II to III NEC, at least 7 days of age at diagnosis and at least 7 days of treatment with bowel rest and antibiotics. Clinical signs included abdominal distention, ileus and hematochezia. Radiographic signs included fixed dilated loops, pneumatosis intestinalis, portal venous gas and pneumoperitoneum. We excluded patients in whom a diagnosis of spontaneous intestinal perforation was made at the time of laparotomy, as well as repeat episodes of NEC in the same patient.
Medical records were reviewed for demographic and clinical variables. The time of NEC diagnosis was defined as the time of the initial abdominal radiograph that led to the diagnosis of NEC. Cases were classified as medical or surgical, the latter defined as peritoneal drain placement or laparotomy within 7 days of NEC diagnosis. Mortality was considered within 14 days of NEC diagnosis.
HRC index monitoring
The HRC (HeRO) monitor (Medical Predictive Science Corporation, Charlottesville, VA, USA) uses the electrocardiogram from standard NICU bedside monitors to continuously calculate an HRC index. The mathematical algorithm from which the HRC index is derived incorporates decreased variability and transient decelerations and, using logistic regression, is the fold increase in probability of sepsis being diagnosed in the next 24 h. The monitor continuously displays the HRC index, which is updated hourly and represents HRC over the previous 12 h. In the randomized trial, clinicians were educated about the HRC index but no course of action was mandated for patients with a rising score.
Statistical analysis
Comparisons of hourly HRC index between the two groups (medical and surgical NEC) were made by t-test for continuous variables and Fisher's exact test for categorical variables. Paired signed rank test was used to analyze the rise in the HRC index before NEC diagnosis. Average HRC index±s.d. is given, unless otherwise noted. Statistical analyses were performed in MatLab (MathWorks, Natick, MA, USA) with a two-tailed level of significance of 0.05.
RESULTS
Patient demographics and clinical course
We identified 97 episodes of NEC Bell's stage II to III in VLBW infants o34 weeks gestation with HRC data available at the time of diagnosis. Thirty-three of these patients underwent either laparotomy or peritoneal drain placement within 7 days of diagnosis and were classified as surgical NEC for this analysis. Clinical characteristics and outcomes are shown in Table 1 . Patients who had surgical intervention (laparotomy or peritoneal drain placement) within 1 week of NEC diagnosis were of lower gestational age, were more likely to have a positive blood culture, and were more likely to die within 14 days of NEC diagnosis. Figure 1 shows screen shots from the HRC monitor, with representative examples of normal HRC and abnormal HRC occurring before clinical presentation of NEC.
HRC index in infants with medical and surgical NEC The baseline HRC index from 1 to 3 days before NEC diagnosis was higher in patients who developed surgical vs medical NEC (2.06±1.98 vs 1.22±1.10, P ¼ 0.009), and this difference persisted after adjustment for gestational age and birth weight. In the hours leading up to the clinical diagnosis of NEC, there was a significant rise in the HRC index over patients' prior 24 h baseline ( Figure 2 ). This occurred 16 h before clinical diagnosis of surgical NEC and 6 h before diagnosis of medical NEC.
At the time of diagnosis, patients with surgical NEC had a higher average HRC index compared with those with medical NEC (3.3±2.2 vs 1.9±1.7, Po0.001), and patients who died had a higher HRC index compared with survivors (4.0 ± 1.9 vs 2.5 ± 1.7, P ¼ 0.004; Table 1 ). Blood culture within 24 h of NEC diagnosis was positive in 22 cases, negative in 74 and not obtained in 1. The HRC index in patients with a positive blood culture was 3.0 ± 1.5 and in those with a negative blood culture was 2.6 ± 1.9 (P ¼ 0.44). Considering only patients with a negative blood culture at the time of NEC diagnosis, there was a significantly higher HRC index in those with surgical compared with those with medical NEC (3.8 ± 2.0 vs 2.2 ± 1.7, P ¼ 0.007).
After NEC diagnosis, the HRC index increased in both groups, peaking 15 h after clinical diagnosis ( Figure 2 ). Of note, general anesthesia and surgery lead to abnormal HRC, and the figure therefore displays the HRC index only before surgical intervention.
HRC index display vs non-display
Of the 97 patients with NEC, 88 patients had been enrolled, with parental consent, in a RCT, in which the HRC index was either displayed to clinicians or not displayed (47 randomized to HRC display and 41 to non-display). The remaining nine patients were at the University of Virginia and were not enrolled in the RCT but had HRC monitored and not displayed to clinicians, per unit protocol. Thus, there were 47 patients with HRC displayed and 50 non-displayed. Figure 3 shows the HRC index around the time of NEC diagnosis in patients in the non-display group compared with the HRC display group.
DISCUSSION
Identification of biomarkers for prediction or early detection of NEC has been the subject of intense investigation, which is appropriate given the high incidence and potentially devastating consequences of the disease. In the current analysis of VLBW infants admitted to three centers during a RCT of HRC monitoring, we found that abnormal HRC similar to those seen in sepsis also occur in preterm infants before clinical presentation of NEC. If clinicians are alerted to this physiologic change they may be prompted to closely evaluate the patient and consider further testing and treatment, potentially leading to improved outcomes through early intervention. Prior studies of NEC biomarkers have not yet yielded clinically useful tests. Daily calculation of the Score for Neonatal Acute Physiology-II, which includes measures of hypotension, hypothermia, acidosis and oxygenation, was shown not to predict or detect NEC. 25 Genetic susceptibility testing, breath hydrogen sampling, and testing for inflammatory markers in blood or stool have all been shown to have limited diagnostic value. 26 Measurements of altered mesenteric blood flow 27, 28 and changes in intestinal microbiota 29 show promise for predicting or detecting NEC, but are in early stages of investigation. Our study indicates that a commercially available monitor that is FDA cleared for reporting on abnormal HRC in neonates can detect biological changes associated with NEC up to a day before clinicians recognize that a patient is ill.
Abnormal HRC of decreased variability and decelerations were discovered by our group to be strongly associated with late-onset sepsis in preterm infants. 9, [30] [31] [32] As NEC shares pathophysiologic features with sepsis, it is not surprising that HRC are abnormal in infants at the time of diagnosis of NEC. The systemic inflammatory response, intestinal distension and tissue necrosis may all contribute indirectly (via autonomic nervous system activation and dysfunction) or directly (via effects on sinoatrial node pacemaker cells) to abnormal HRC. In the current analysis, we found that the HRC index continued to rise after diagnosis and the start of treatment of NEC, in contrast to sepsis where we previously have shown that peak HRC occurs near the time of diagnosis and declines after antibiotics and other therapies are started. The continued worsening of HRC in patients with NEC parallels the clinical course in these infants in whom a dramatic systemic inflammatory response and, in some cases, significant bowel necrosis, often lead to progressive clinical deterioration even after initiation of therapy. The clinical relevance of this finding is that, in NICU patients started on antibiotics for suspected infection, a continued rise in the HRC index could be a sign of an ongoing inflammatory process and should lead to careful clinical assessment and consideration of additional studies or therapies.
Most patients in the current analysis were participating in a RCT of 3003 VLBW infants, in which the HRC index was monitored in all infants but displayed to clinicians in only half. In this large clinical trial, mortality was significantly reduced in patients who had their . Heart rate characteristics (HRC) index in infants with necrotizing enterocolitis (NEC) with HRC index displayed or not displayed to clinicians. Of 97 infants with NEC, 88 were enrolled in a clinical trial of HRC monitoring in which infants were randomized to having their HRC index displayed to clinicians and 9 had HRC monitored but not displayed outside the clinical trial. Average HRC index is shown before and after NEC diagnosis at day 0 for infants with HRC displayed (solid line, n ¼ 47) or not displayed (dashed line, n ¼ 50). HRC index continuously displayed. In the current analysis, we did not find a statistically significant difference in the average HRC index before NEC diagnosis in infants in the HRC display and non-display groups. A limitation of the current analysis is that the number of infants was small, and in the RCT there was no mandated intervention for infants with an acute rise in their HRC index. A larger number of infants with NEC would be required to determine whether display of the HRC index leads to earlier treatment or improved outcomes.
CONCLUSION
Earlier diagnosis of NEC and institution of therapies to decrease the metabolic demand (bowel rest), reduce intestinal distension (gastric decompression), treat infection (broad-spectrum antibiotics) and optimize tissue oxygen delivery (fluid resuscitation and blood pressure support) may improve outcomes. Newer therapies for NEC such as anti-inflammatory agents 33 may also be more effective if patients can be identified in the early phases of illness. Continuous monitoring of HRC provides clinicians with information about subtle physiologic changes associated with the systemic inflammatory response that precede clinical deterioration associated with NEC, raising the possibility of improving patient outcomes through earlier intervention.
CONFLICT OF INTEREST
